Home
Department of Clinical Medicine

News archive for Department of Clinical Medicine

Getting started on a manuscript or scientific text can often feel like the hardest part. Wouldn't it be great to have expert guidance to kickstart the process? That’s exactly what seventy-five students and several researchers signed up for when they filled the auditorium for this year’s CCBIO908 Scientific Writing & Communication Seminar, held May 20–21, 2025.
This April, the CCBIO cup traveled far beyond its usual surroundings—all the way to the Himalayas, accompanying CCBIO Principal Investigator Professor Daniela Elena Costea from the University of Bergen (UiB) on a remarkable health charity mission. The destination: Manang, a remote village located at 3,540 meters in the mountains of Nepal.
On June 10, 2025, the Research Council of Norway announced funding for new projects in the FRIPRO scheme. Of the 3 awarded projects to the UiB, CCBIO Postdoc Harsh Dongre in Dana Costea's group received 3-year project support with international mobility.
For the first time, a Nobel Symposium has been dedicated to Multiple Sclerosis (MS), bringing global experts to Stockholm on June 2–5, 2025. Hosted at the Karolinska Institutet, the symposium - “Multiple Sclerosis: From Molecular Mechanisms to Disease-Modifying Treatments” - features leading researchers from Europe and the U.S., including several key members of the EBV-MS consortium.
Highlights from the Mystery Solved Project 2025
A new video from the EBV-MS research project is set to shed light on the role of the Epstein-Barr virus (EBV) in multiple sclerosis (MS), offering a glimpse into the pioneering research efforts and the personal experiences of those involved. The EBV-MS project, funded by Horizon Europe and led by the University of Bergen, aims to unravel why only some people infected with EBV go on to develop MS... Read more
The 13th CCBIO Annual Symposium at Solstrand marks a shift in the strategy of the center, towards more focus on innovation and industry development.
The Renal Research Group wins the prize of the best research environment in 2024
The Renal Research Group is organizing Bergen Meeting of Nephrology on May 8th 2025 at Haukeland University Hospital (B-302)
Honorary Doctor at UiB, Alberto Ascherio, receives the prize for his groundbreaking research on MS.
Over two months in October–December 2024, PhD Candidate Ghazal Lessan Toussi in Carina Strell’s group at CCBIO was given the opportunity to be on a research lab stay in Dr. Watnick’s laboratory at Boston Children's Hospital in Boston, USA. This was organized in the CCBIO–VBP Lab Visit Program, which is part of the CCBIO INTPART collaboration. Ghazal returned with lots of new knowledge and... Read more
CCBIO Postdoc Harsh Dongre is currently in his 11th month in Boston on his research year abroad. Now that he soon will be returning, we have asked him to reflect a little bit about doing a year abroad as part of a career path, why he chose Boston, and what he has been doing there.
12 mill NOK was today (Dec. 20, 2024) awarded to Lars A. Akslen and Heidrun Vethe from the Research Council of Norway (FRIPRO) on the project "When breast cancer hits a nerve - neural involvement as a hallmark of tumor progression."
The Western Norway Regional Health Authorities (Helse Vest) has recently announced their project funding for 2025, and we are happy to see many Neuro-SysMed researchers in their announcement. In addition, other funding agencies have also granted support to our projects this fall.
CCBIO has a tradition of using the December meeting in its seminar series to add a different perspective and encourage our research environment to think outside of the box. This December, we had the pleasure of welcoming back Fran Balkwill, who has a unique experience in addition to her cancer research career.
The result of years of collaboration between CCBIO PI Jim Lorens and Rolf Brekken and other colleagues in the USA, Finland, Romania and Norway, is now published in Science Signaling, with research identifying nuclear AKT3 as a new biomarker of advanced malignancy and revealing the pathway that activates AKT3 to drive epithelial-to-mesenchymal transition in pancreatic cancer.

Pages